NDSN vs ITT vs IEX
161 measures in 16 categories, one definition each, computed from filings and market data.
NDSN74.8
Nordson Corporation
Industrials · Industrial - Machinery
$322.31 −1.97%$18.0B mkt cap
Score DNA
IEX67.0
IDEX Corporation
Industrials · Industrial - Machinery
$235.55 −0.37%$17.4B mkt cap
Score DNA
Price, rebased to 100 three years ago
NDSN ITT IEX · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | NDSN | ITT | IEX |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 1 | 0 |
| Insider $ bought, 180d | — | $1.00M | — |
| Congress purchases, 180d | 0 | 0 | 0 |
| Last Congress purchase | — | — | — |
| 13F net change in holders | +44 | +3 | +15 |
| ETFs adding shares, 30d | 784 | 358 | 891 |
| ETFs trimming, 30d | 636 | 256 | 802 |
| Net ETF funds, 30d | +148 | +102 | +89 |
Valuation
16 measures| Measure | NDSN | ITT | IEX |
|---|---|---|---|
| P/E (TTM) | 32.3x
65th
|
42.1x
85th
|
33.4x
69th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 7.35
83rd
|
— | — |
| Price / sales | 6.0x
98th
|
3.7x
74th
|
4.8x
89th
|
| Price / book | 5.5x
78th
|
3.7x
50th
|
4.3x
63rd
|
| Price / tangible book | — | — | — |
| Price / free cash flow | 24.6x
59th
|
34.8x
86th
|
27.1x
70th
|
| Price / operating cash flow | 23.1x
74th
|
28.0x
88th
|
24.2x
79th
|
| Enterprise value | $19.7B
75th
|
$21.0B
77th
|
$18.6B
74th
|
| EV / sales | 6.6x
98th
|
4.4x
77th
|
5.2x
85th
|
| EV / EBITDA | 20.7x
77th
|
22.6x
84th
|
19.4x
70th
|
| EV / EBIT | 24.6x
67th
|
29.7x
80th
|
25.0x
69th
|
| EV / free cash flow | 27.0x
52nd
|
41.2x
88th
|
29.0x
57th
|
| Earnings yield | 3.1%
43rd
|
2.4%
25th
|
3.0%
39th
|
| FCF yield | 4.1%
46th
|
2.9%
21st
|
3.7%
36th
|
| Operating cash flow yield | 4.3%
30th
|
3.6%
16th
|
4.1%
25th
|
| Graham number (per share) | $114.06
87th
|
$75.14
72nd
|
$92.25
78th
|
Profitability (TTM)
12 measures| Measure | NDSN | ITT | IEX |
|---|---|---|---|
| Gross margin | 55.3%
100th
|
34.6%
43rd
|
44.7%
87th
|
| EBITDA margin | 31.8%
98th
|
19.6%
57th
|
26.7%
92nd
|
| Operating margin | 26.9%
98th
|
16.0%
66th
|
20.8%
87th
|
| EBIT margin | 26.8%
97th
|
14.9%
59th
|
20.8%
90th
|
| Net margin | 18.6%
95th
|
8.9%
52nd
|
14.5%
84th
|
| NOPAT margin | 22.1%
98th
|
11.2%
52nd
|
15.8%
84th
|
| FCF margin | 24.4%
93rd
|
10.7%
44th
|
17.9%
87th
|
| Operating cash flow margin | 26.1%
93rd
|
13.3%
44th
|
20.0%
85th
|
| R&D / revenue | 0.0%
0th
|
2.6%
79th
|
0.0%
0th
|
| SG&A / revenue | 28.4%
95th
|
14.7%
30th
|
23.7%
77th
|
| Stock comp / revenue | 0.4%
22nd
|
0.6%
50th
|
0.8%
63rd
|
| Effective tax rate | 17.7%
20th
|
29.7%
95th
|
23.8%
72nd
|
Returns on capital
11 measures| Measure | NDSN | ITT | IEX |
|---|---|---|---|
| ROE (on average equity) | 17.8%
71st
|
11.5%
44th
|
13.0%
53rd
|
| ROA | 9.3%
69th
|
5.3%
41st
|
7.5%
64th
|
| ROIC | 13.3%
64th
|
6.6%
28th
|
10.8%
49th
|
| ROCE | 15.3%
74th
|
8.1%
39th
|
11.7%
54th
|
| Return on tangible assets | 13.4%
77th
|
8.8%
46th
|
10.8%
59th
|
| Cash ROIC (OCF / invested capital) | 15.7%
63rd
|
7.9%
18th
|
13.6%
55th
|
| Gross profitability (GP / assets) | 27.7%
69th
|
14.9%
11th
|
23.1%
39th
|
| ROIC, 3-yr average | 10.5%
58th
|
10.5%
60th
|
9.3%
54th
|
| ROIC, 5-yr average | 13.4%
58th
|
16.5%
77th
|
12.5%
55th
|
| ROE, 5-yr average | 18.0%
69th
|
16.2%
59th
|
15.4%
56th
|
| Incremental ROIC | -152.2%
15th
|
3.4%
31st
|
— |
Growth
17 measures| Measure | NDSN | ITT | IEX |
|---|---|---|---|
| Revenue growth (TTM YoY) | 7.0%
47th
|
28.1%
90th
|
7.3%
50th
|
| Revenue growth (QoQ) | 10.4%
56th
|
21.6%
87th
|
3.8%
16th
|
| Revenue CAGR, 3 yr | 4.7%
66th
|
14.5%
90th
|
2.5%
39th
|
| Revenue CAGR, 5 yr | 5.1%
44th
|
12.0%
84th
|
7.2%
58th
|
| Gross profit CAGR, 3 yr | 5.5%
49th
|
17.0%
93rd
|
2.3%
22nd
|
| Operating income CAGR, 3 yr | 6.4%
47th
|
12.0%
67th
|
-2.7%
18th
|
| Net income growth (TTM YoY) | 22.0%
73rd
|
-18.6%
24th
|
10.7%
69th
|
| Net income CAGR, 3 yr | 3.5%
49th
|
-0.3%
37th
|
-4.0%
33rd
|
| EPS growth (TTM YoY) | 24.2%
76th
|
-25.9%
22nd
|
12.9%
69th
|
| EPS CAGR, 3 yr | 4.4%
51st
|
-3.1%
37th
|
-3.3%
35th
|
| EPS CAGR, 5 yr | 9.9%
59th
|
44.3%
100th
|
5.0%
37th
|
| FCF growth (TTM YoY) | 34.2%
81st
|
4.4%
37th
|
9.3%
52nd
|
| FCF CAGR, 3 yr | 5.8%
23rd
|
16.9%
57th
|
4.0%
19th
|
| Operating cash flow CAGR, 3 yr | 6.1%
26th
|
14.5%
53rd
|
3.1%
23rd
|
| Book value CAGR, 3 yr | 9.2%
54th
|
23.5%
93rd
|
7.7%
43rd
|
| Dividend CAGR, 3 yr | 2.0%
48th
|
1.8%
46th
|
1.2%
40th
|
| Sustainable growth rate | 11.9%
61st
|
8.1%
43rd
|
7.6%
39th
|
Margin history & stability
7 measures| Measure | NDSN | ITT | IEX |
|---|---|---|---|
| Gross margin, 3-yr average | 55.0%
100th
|
34.6%
43rd
|
44.1%
85th
|
| Operating margin, 3-yr average | 25.6%
97th
|
17.1%
75th
|
21.2%
95th
|
| Net margin, 3-yr average | 17.6%
95th
|
11.8%
67th
|
15.6%
90th
|
| FCF margin, 3-yr average | 21.8%
98th
|
12.2%
60th
|
18.5%
95th
|
| Revenue stability (0-1) | 0.98
95th
|
0.88
63rd
|
0.83
57th
|
| Earnings stability (0-1) | 0.52
62nd
|
0.61
65th
|
0.09
23rd
|
| Margin stability (0-1) | 0.99
97th
|
0.96
72nd
|
0.99
95th
|
Liquidity (latest quarter)
7 measures| Measure | NDSN | ITT | IEX |
|---|---|---|---|
| Cash & short-term investments | $113.4M
34th
|
$590.8M
75th
|
$621.3M
77th
|
| Net cash (− = net debt) | −$1.7B
31st
|
−$3.2B
16th
|
−$1.3B
41st
|
| Working capital | $599.4M
51st
|
$593.1M
49th
|
$1.2B
82nd
|
| Current ratio | 1.82
38th
|
1.26
16th
|
3.05
89th
|
| Quick ratio | 1.18
49th
|
0.85
23rd
|
2.15
90th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.16
25th
|
0.26
48th
|
1.07
90th
|
| Defensive interval (days) | 329 days
21st
|
720 days
77th
|
497 days
52nd
|
Leverage & solvency (latest quarter)
13 measures| Measure | NDSN | ITT | IEX |
|---|---|---|---|
| Total debt | $1.8B
61st
|
$3.8B
82nd
|
$1.9B
62nd
|
| Debt / equity | 0.55
52nd
|
0.80
77th
|
0.47
38th
|
| Net debt / equity | 0.52
65th
|
0.68
78th
|
0.32
37th
|
| Debt / assets | 30.5%
62nd
|
34.7%
79th
|
27.2%
52nd
|
| Debt / capital | 35.7%
52nd
|
44.4%
77th
|
32.0%
38th
|
| Debt / EBITDA | 1.91
46th
|
4.13
88th
|
1.97
48th
|
| Net debt / EBITDA | 1.80
57th
|
3.50
86th
|
1.32
38th
|
| Interest coverage (EBIT / interest) | 7.0x
48th
|
7.0x
50th
|
11.7x
64th
|
| Cash interest coverage | 6.8x
38th
|
6.3x
34th
|
11.2x
70th
|
| Debt payback (years of OCF) | 2.3 yrs
41st
|
6.1 yrs
86th
|
2.6 yrs
50th
|
| Liabilities / assets | 45.0%
28th
|
56.4%
64th
|
42.2%
16th
|
| IS credit model rating | A | BBB | AA |
| Implied credit spread (bps) | 150
54th
|
275
70th
|
80
10th
|
Efficiency
11 measures| Measure | NDSN | ITT | IEX |
|---|---|---|---|
| Asset turnover | 0.50
16th
|
0.59
31st
|
0.52
18th
|
| Fixed asset turnover | 5.12
33rd
|
5.27
36th
|
7.73
79th
|
| Inventory turnover | 2.9
23rd
|
3.9
62nd
|
3.9
64th
|
| Receivables turnover | 4.8
18th
|
5.2
28th
|
7.1
79th
|
| Days sales outstanding | 76 days
82nd
|
71 days
72nd
|
51 days
21st
|
| Days inventory outstanding | 127 days
77th
|
94 days
38th
|
93 days
36th
|
| Days payables outstanding | 39 days
20th
|
65 days
74th
|
40 days
23rd
|
| Cash conversion cycle (days) | 164 days
90th
|
99 days
36th
|
104 days
46th
|
| Capex / revenue | 1.7%
18th
|
2.6%
62nd
|
2.1%
47th
|
| Capex / depreciation | 0.33
15th
|
0.56
40th
|
0.35
17th
|
| Operating expense ratio | 28.2%
84th
|
22.4%
61st
|
24.6%
72nd
|
Cash flow & earnings quality
7 measures| Measure | NDSN | ITT | IEX |
|---|---|---|---|
| Operating cash flow / net income | 1.40
47th
|
1.50
58th
|
1.38
44th
|
| FCF / net income | 1.31
64th
|
1.21
47th
|
1.23
51st
|
| FCF / operating cash flow | 93.7%
98th
|
80.5%
42nd
|
89.5%
77th
|
| Capex / operating cash flow | 6.3%
2nd
|
19.5%
58th
|
10.5%
23rd
|
| Accruals ratio | -3.7%
46th
|
-2.6%
64th
|
-2.9%
61st
|
| Sloan accruals ratio | -1.5%
51st
|
-3.3%
26th
|
-1.6%
48th
|
| Earnings quality score (0-1) | 1.00
25th
|
1.00
25th
|
1.00
25th
|
Scores & forensic checks
15 measures| Measure | NDSN | ITT | IEX |
|---|---|---|---|
| IS score | 75
95th
|
50
33rd
|
67
82nd
|
| IS profitability | 71
90th
|
37
39th
|
57
69th
|
| IS growth | 61
75th
|
46
45th
|
52
63rd
|
| IS value | 45
33rd
|
43
30th
|
54
69th
|
| IS momentum | 87
87th
|
74
52nd
|
81
73rd
|
| IS risk (safety) | 100
48th
|
65
23rd
|
100
48th
|
| IS quality | 87
97th
|
62
25th
|
81
89th
|
| IS balance sheet | 58
39th
|
50
20th
|
75
74th
|
| IS earnings quality | 71
36th
|
70
34th
|
79
92nd
|
| IS cash flow | 82
95th
|
58
41st
|
68
67th
|
| Piotroski F-score (0-9) | 9
92nd
|
3
2nd
|
8
74th
|
| Altman Z-score | 5.9
77th
|
2.7
25th
|
5.5
66th
|
| Beneish M-score | −2.58
37th
|
−1.82
98th
|
−2.51
57th
|
| Ohlson O-score | −8.67
25th
|
−7.57
59th
|
−8.87
20th
|
| IS credit score | 75
44th
|
55
25th
|
89
90th
|
Size (TTM)
8 measures| Measure | NDSN | ITT | IEX |
|---|---|---|---|
| Market cap | $18.0B
77th
|
$17.7B
75th
|
$17.4B
74th
|
| Revenue | $3.0B
52nd
|
$4.7B
74th
|
$3.6B
62nd
|
| EBITDA | $947.4M
74th
|
$927.7M
70th
|
$957.8M
75th
|
| Net income | $555.2M
75th
|
$421.5M
67th
|
$519.5M
72nd
|
| Free cash flow | $728.5M
75th
|
$509.2M
67th
|
$641.5M
72nd
|
| Total assets | $5.9B
64th
|
$11.0B
77th
|
$6.9B
70th
|
| Shareholders' equity | $3.3B
70th
|
$4.8B
80th
|
$4.0B
77th
|
| Employees | 8,200
56th
|
11,600
70th
|
8,700
57th
|
Price performance
9 measures| Measure | NDSN | ITT | IEX |
|---|---|---|---|
| 1 day | −2.0% | −1.3% | −0.4% |
| 1 week | −1.8% | −1.4% | +0.5% |
| 1 month | +3.4% | −2.1% | +6.5% |
| 3 months | +13.0% | +3.8% | +6.8% |
| 6 months | +14.3% | −9.4% | +15.5% |
| Year to date | +33.7% | +13.9% | +33.4% |
| 1 year | +39.5% | +15.0% | +46.3% |
| 3 years, cumulative | +45.6% | +100.5% | +17.8% |
| 5 years, cumulative | +42.4% | +129.8% | +19.0% |
Technicals
4 measures| Measure | NDSN | ITT | IEX |
|---|---|---|---|
| RSI 14 | 46.5 | 43.2 | 58.0 |
| From 52-week high | −5.0% | −13.8% | −3.1% |
| From 52-week low | +44.9% | +18.9% | +48.7% |
| Beta | 0.99 | 1.25 | 0.96 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17